| | COMPOUND: C07036 | |
Entry |
|
Name |
|
Formula |
C10H22N4
|
Exact mass |
198.1844
|
Mol weight |
198.3085
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING
C02CC Guanidine derivatives
C02CC02 Guanethidine
D08030 Guanethidine (INN)
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EX Other antiglaucoma preparations
S01EX01 Guanethidine
D08030 Guanethidine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01739 Peripherally-acting antiadrenergic
DG00258 Guanethidine
D08030 Guanethidine
Neuropsychiatric agent
DG03085 Selective norepinephrine reuptake inhibitor (NRI)
DG00258 Guanethidine
D08030 Guanethidine
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG00258 Guanethidine
D08030 Guanethidine
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC6
SLC6A2 (NAT1)
D08030 Guanethidine (INN)
|
Other DBs |
|
KCF data |
ATOM 14
1 N1y N 32.5637 -14.9408
2 C1b C 31.3813 -14.2592
3 C1x C 32.5170 -16.4201
4 C1x C 33.5772 -13.9330
5 C1b C 30.1989 -14.9408
6 C1x C 33.5772 -17.3929
7 C1x C 34.9868 -13.9330
8 N1b N 29.0166 -14.2592
9 C1x C 34.9809 -17.3929
10 C1x C 35.9944 -14.9408
11 C2c C 27.8342 -14.9408
12 C1x C 35.9886 -16.3968
13 N1a N 26.6459 -14.2592
14 N2a N 27.8342 -16.3037
BOND 14
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 4 7 1
7 5 8 1
8 6 9 1
9 7 10 1
10 8 11 1
11 9 12 1
12 11 13 1
13 11 14 2
14 10 12 1
|
|
» Japanese version
|
|